When a clinician evaluates male pattern hair loss, one of the first tools they may use is the Norwood Scale. It is the most widely used classification system for male androgenetic alopecia, and it does more than describe how much hair a man has lost. It frames how treatment should be approached, what outcomes are realistic, and which treatments are likely to produce meaningful results. Understanding the scale can help patients make sense of their diagnosis and know what to expect.
The Origins of the Norwood Scale
Dr. James Hamilton first developed the scale in the 1950s to describe common patterns of male pattern baldness. In 1975, Dr. O'Tar Norwood revised and expanded it, producing the version most clinicians use today — formally called the Hamilton-Norwood Scale.
It describes seven stages of hair loss. Some stages also have subtypes that show pattern differences. Each stage is defined by where loss is occurring, how extensive it is, and whether the hairline and crown are affected independently or in combination.
The Norwood Scale is a diagnostic and prognostic tool. It tells a clinician not just where a patient is today, but — based on pattern — where they are likely to be without treatment.
The Seven Stages
Type I: Minimal recession. A slightly irregular hairline at the temples that is not significant. Most men in their 20s fall in this range. No treatment is medically necessary, though early treatment is an option for men with a strong family history.
Type II: Slight recession at the temples forming a symmetrical pattern. The hairline has moved back slightly. Hair at the crown is unaffected. The pattern is becoming established but loss is limited.
Type III: The first stage at which recession is considered important. Temples are deeply recessed, forming an M, U, or V shape. Type III Vertex is a subtype where significant thinning at the crown begins alongside or instead of frontal recession.
Type IV: Significant recession at both the hairline and the crown. A bridge of hair separates the two areas. Loss is visually significant from multiple angles.
Type V: The bridge of hair between the frontal and crown areas thins considerably. The two regions of loss are beginning to merge. Hair loss is extensive.
Type VI: The frontal and crown regions have merged. A band of hair on the sides and back of the scalp remains, but the top of the head is largely bald or meaningfully thinned.
Type VII: The most advanced stage. Loss extends to the sides and back, leaving only a narrow band of hair around the lowest part of the scalp. This is the most severe pattern.
Most men who seek treatment are at Norwood Types II through V. Types VI and VII represent advanced loss where treatment can slow progression and improve the appearance of the remaining hair, but significant regrowth is unlikely.
What the Scale Means for Treatment Planning
A person’s Norwood stage can shape the treatment plan in several ways.
Types II and III: These are the stages where treatment produces the best outcomes. Follicles are still in the miniaturization process. They are alive and responsive. DHT inhibitors like finasteride or dutasteride can slow or halt the process, and minoxidil can stimulate recovery of miniaturized follicles. Men who start treatment at Type II or early Type III have the highest probability of maintaining their hair and achieving meaningful regrowth.
Types III through V: Treatment remains effective, but the goals shift somewhat. Halting progression is often the primary aim. Regrowth is possible in areas of active miniaturization, but fully bald areas from long-standing loss may take longer to recover, if at all. Combination therapy (a 5-alpha reductase inhibitor plus minoxidil) is the standard recommendation.
Types V through VII: At these stages, treatment can slow continued loss and may improve the density of hair in partially thinned areas. The fully bald areas that have been without follicular activity for years may not respond. For men with advanced loss who want restoration rather than maintenance, surgical hair transplant becomes a relevant consideration alongside medical management.
The earlier the Norwood Stage at which treatment begins, the better the outcome. Every stage of delay moves more follicles from reversible miniaturization to permanent dormancy.
The Crown vs. Hairline Distinction
Treatment responds differently in different regions of the scalp, and the Norwood Stage captures this.
The crown (vertex) typically responds better to both finasteride and minoxidil than the frontal hairline. The pivotal finasteride trial found that vertex hair count increased by an average of 107 hairs per cm² at one year, while frontal hairline response was less consistent.
This is not unique to finasteride. Minoxidil also shows stronger response at the vertex than at the temples. Frontal hairline follicles often become harder to recover once recession is established.
This matters for patients with Type III Vertex or Type IV patterns that are predominantly crown-based — they are often good candidates for meaningful regrowth. Patients whose primary concern is a receding hairline should have realistic expectations about the degree of frontal recovery achievable with medical therapy alone.
Crown loss responds better to medical treatment than hairline recession. Norwood Stage and the pattern of loss together determine what regrowth is realistically achievable.
Limitations of the Scale
The Norwood Scale is a useful clinical tool but has limitations. It was developed in predominantly white male populations and may not entirely capture the range of patterns seen in men of other ethnicities. It also does not classify female pattern hair loss. A separate classification system, the Ludwig Scale, is used for women.
The scale also does not account for diffuse thinning across the entire scalp, a pattern sometimes seen in younger men, that does not fit neatly into the Norwood’s regional classification categories.
In spite of these limitations, it remains the most practical and widely used reference framework in clinical hair loss assessment.
The Norwood Scale is a useful but imperfect tool. It is most reliable as a communication and planning framework rather than a precise prognostic instrument used in isolation. Summary
The Norwood Scale classifies male pattern hair loss into seven stages from minimal recession to near-complete loss. It is an important framework for treatment planning because the stage at presentation determines both what outcomes are realistic and what treatments are most appropriate. Earlier stages (II through IV) offer the best chance of meaningful regrowth and long-term maintenance. Later stages (V through VII) shift the goal toward slowing progression and improving existing hair density. Generally, crown loss responds better to medical treatment than frontal hairline recession.